Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus

This study has been completed.
Sponsor:
Collaborator:
Biogen
Information provided by (Responsible Party):
UCB Pharma
ClinicalTrials.gov Identifier:
NCT01764594
First received: January 2, 2013
Last updated: July 14, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)